L-type Ca2+ channel agonist inhibits RANKL-induced osteoclast formation via NFATc1 down-regulation

Life Sciences

Volumn 89, Issue 5-6, 2011, Pages 159-164

  Sae Mi Noh, A Long ^a   Park, Hyojung ^a   Zheng, Ting ^a   Ha, Hyun Il ^b   Yim, Mijung ^a  

^a Sookmyung Women's University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

BayK 8644; Osteoclast

Indexed keywords

BAYK 8644; CALCIUM CHANNEL STIMULATING AGENT; COLONY STIMULATING FACTOR 1; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 80051795594     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.05.009     Document Type: Article

References (30)

1. Axmann R, Böhm C, Krönke G, Zwerina J, Smolen J, Schett G. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 2009;60:2747-56.
2. Blair HC, Robinson LJ, Zaidi M. Osteoclast signalling pathways. Biochem Biophys Res Commun 2005;328:728-38. (Pubitemid 40208310)
3. Bootman MD, Berridge MJ. The elemental principles of calcium signaling. Cell 1995;83: 675-8.
4. Clapham DE. Calcium signaling. Cell 2007;131:1047-58.
5. 2+ response amplitude and duration. Nature 1997;386:855-8. (Pubitemid 27181262)
6. Hartgers FC, Vissers JL, Looman MW, van ZoelenC, Huffine C, Figdor CG, etal. DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol 2000;30:3585-90. (Pubitemid 32005231)
7. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002;277:41147-56. (Pubitemid 35215706)
8. Kim K, Lee SH, Ha Kim J, Choi Y, Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 2008;22:176-85.
9. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 2004;200:941-6. (Pubitemid 39362930)
10. Lacinová L. Voltage-dependent calcium channels. Gen Physiol Biophys 2005;24(Suppl 1): 1-78. (Pubitemid 41025303)
11. Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2006a;12:1403-9. (Pubitemid 44924499)
12. Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. Bone 2006b;38:678-85.
13. Li Z, Kong K, Qi W. Osteoclast and its roles in calcium metabolism and bone development and remodeling. Biochem Biophys Res Commun 2006;343:345-50.
14. Mentaverri R, Yano S, Chattopadhyay N, Petit L, Kifor O, Kamel S, et al. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 2006;20:2562-4.
15. Miyauchi A, Hruska KA, Greenfield EM, Duncan R, Alvarez J, Barattolo R, et al. Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption. J Cell Biol 1990;111(6 Pt 1):2543-52. (Pubitemid 120014537)
16. Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 1998;253:395-400. (Pubitemid 29026714)
17. Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K. RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways. Biochem Biophys Res Commun 2007;357:945-50. (Pubitemid 46693662)
18. 2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev 2009;231:241-56.
19. Nelson N, Harvey WR. Vacuolarand plasma membrane proton- adenosinetriphosphatases. Physiol Rev 1999;79:361-85.
20. Ritchie CK, Maercklein PB, Fitzpatrick LA. Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations. Endocrinology 1994;135:996-1003. (Pubitemid 24271190)
21. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289: 1508-14.
22. Ruocco MG, Maeda S, Park JM, Lawrence T, Hsu LC, Cao Y, et al. I(kappa)B kinase (IKK) (beta), but not IKK(alpha), is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med 2005;201:1677-87.
23. Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 2006;12:1410-6. (Pubitemid 44924500)
24. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-57. (Pubitemid 30649812)
25. 2+ signaling, cell activation and cell survival in immune cells. Mol Immunol 2010;47: 640-8.
26. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988;123: 2600-2.
27. Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, et al. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J Bone Miner Res 2005;20:653-62. (Pubitemid 40393074)
28. Takayanagi H. The role of NFAT in osteoclast formation. Ann N Y Acad Sci 2007;1116: 227-37. (Pubitemid 350274348)
29. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002;3:889-901. (Pubitemid 35460788)
30. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005;202:345-51. (Pubitemid 41126951)